MODIFICATION TO: SATELLITE SPINAL SYSTEM
Device Facts
| Record ID | K060415 |
|---|---|
| Device Name | MODIFICATION TO: SATELLITE SPINAL SYSTEM |
| Applicant | Medtronic Sofamor Danek |
| Product Code | NVR · OR |
| Decision Date | Jan 5, 2007 |
| Decision | SESU |
| Submission Type | Traditional |
| Device Class | Class 3 |
| Attributes | Therapeutic |
Indications for Use
The SATELLITE™ Spinal System is intended to be inserted between the vertebral bodies into the disc space from L3 to S1 to help provide stabilization and to help promote intervertebral body fusion. This internal fixation device is intended for, and designed solely for holding bone parts in alignment while they heal. The SATELLITE™ Spinal System is intended to be used with bone graft.
Device Story
SATELLITE™ Spinal System consists of spheres implanted into the disc space between L3-S1 vertebrae; provides temporary stabilization to promote intervertebral body fusion. Used with bone graft; functions as internal fixation to hold bone parts in alignment during healing. Operated by surgeons in clinical settings. Subject device adds PEEK-OPTIMA LT1 spheres with Tantalum markers to existing cobalt chrome system. Benefits patient by facilitating spinal fusion.
Clinical Evidence
No clinical data provided. Substantial equivalence established via bench testing and design comparison to the predicate device.
Technological Characteristics
Spheres manufactured from cobalt chrome or medical grade PEEK-OPTIMA LT1. PEEK spheres include Tantalum markers for radiopacity. Designed for insertion into L3-S1 disc space. Non-active, mechanical implant.
Indications for Use
Indicated for patients requiring intervertebral body fusion in the lumbar/sacral spine (L3-S1) to provide stabilization and hold bone parts in alignment during healing. Must be used with bone graft. Contraindicated for motion sparing, non-fusion procedures.
Regulatory Classification
Identification
Intended to be inserted between the vertebral bodies into the disc space from l3 to s1 to provide stabilization and to help promote intervertebral body fusion. To be used with bone graft, for holding bone parts in alignment while they heal. Not intended for use in motion-sparing, non-fusion procedures, helps promote intervertebral body fusion, please reference: https://www.federalregister.gov/documents/2023/03/30/2023-06566/medical-devices-orthopedic-devices-classification-of-spinal-spheres-for-use-in-intervertebral-fusion.
Predicate Devices
- SATELLITE™ Spinal System (K051320)
Submission Summary (Full Text)
{0}------------------------------------------------
A final rule classifying spinal spheres for use in intervertebral fusion procedures, a preamendments, unclassified device type, into class III (premarket approval), was published on March 30, 2023. See here: https://www.federalregister.gov/documents/2023/03/30/2023-06566/medical-devices-orthopedic-devices-classification-of-spinalspheres-for-use-in-intervertebral-fusion. Concurrently, FDA published a final order to require the filing of a premarket approval application (PMA) for spinal spheres for use in intervertebral fusion procedures. See here: https://www.federalregister.gov/documents/2023/03/30/2023-06565/effective-date-of-requirement-for-premarket-approvalapplications-for-spinal-spheres-for-use-in.
Please refer to the aforementioned final rule and final order for current regulatory requirements for this device type.
{1}------------------------------------------------
K060415
## SATELLITE™ SPINAL SYSTEM 510(k) Summary February 2006
JAN - 5 2007 I. Company: Medtronic Sofamor Danek 1800 Pyramid Place Memphis, TN 38132 (901) 396-3133
Contact: Edward S. Chin Group Director, Clinical and Regulatory Affairs
- II. Proprietary Trade Name: SATELLITE™ Spinal System
- Classification Name: Orthosis, Spinal Intervertebral Fusion, Solid Sphere III.
- Regulation Number: Preamendment Device IV.
- V. Product Code: NVR
#### VI. Product Description
The SATELLITE™ Spinal System consists of spheres manufactured from either cobalt chrome or medical grade PEEK-OPTIMA LT1, which may be implanted from L3-S1 to provide temporary stabilization in order to help promote fusion.
#### VII Indications
The SATELLITE™ Spinal System is intended to be inserted between the vertebral bodies into the disc space from L3 to S1 to help provide stabilization and to help promote intervertebral body fusion. This internal fixation device is intended for, and designed solely for holding bone parts in alignment while they heal. The SATELLITE™ Spinal System is intended to be used with bone graft.
#### VIII Substantial Equivalence
The purpose of this submission was to add PEEK-OPTIMA LT1 spheres with Tantalum markers to the system. Documentation was provided which demonstrated the subject SATELLITE™ Spinal System devices to be substantially equivalent to the cobalt chrome SATELLITE™ Spinal System devices previously cleared in K051320 (SE 09/09/05).
# 000033
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the seal of the U.S. Department of Health and Human Services. The seal features an abstract image of an eagle with its wings spread. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Medtronic Sofamor Danek % Ms. Christine Scifert Group Director, Regulatory Affairs 1800 Pyramid Place Memphis, Tennessee 38132
JAN - 5 2007
Re: K060415/S1
Trade Name: SATELLITE® Spinal System Regulatory Class: Unclassified Product Code: NVR Dated: September 28, 2006 Received: September 29, 2006
Dear Ms. Scifert:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act and the limitations described below. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
The Office of Device Evaluation has determined that there is a reasonable likelihood that this device will be used for an intended use not identified in the proposed labeling and that such use could cause harm. Therefore, in accordance with Section 513(i)(1)(E) of the Act, the following limitation must appear in the Warnings section of the device's labeling:
"The safety and effectiveness of this device for use in motion sparing, non-fusion procedures has not been established."
Please note that the above labeling limitations are required by Section 513(i)(1)(E) of the Act. Therefore, a new 510(k) is required before these limitations are modified in any way or removed from the device's labeling.
The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and permits your device to proceed to the market. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification if the limitation statement described above is added to your labeling.
{3}------------------------------------------------
### Page 2 - Ms. Christine Scifert
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements aft the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific information about the application of other labeling requirements to your device (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International, and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address <http://www.fda.gov/cdrh/industry/support/index.html>.
Sincerely yours,
Donna-Bea Tillman, Ph.D., M.P.A. Director Office of Device Evaluation Center for Devices and Radiological Health
2
Enclosure
{4}------------------------------------------------
510(k) Number (if known): KO60415
Device Name: SATELLITE™ Spinal System
Indications for Use:
The SATELLITE™ Spinal System is intended to be inserted between the vertebral bodies into the disc space from L3 to S1 to help provide stabilization and to help promote intervertebral body fusion. This internal fixation device is intended for, and designed solely for holding bone parts in alignment while they heal. The SATELLITE™ Spinal System is intended to be used with bone graft.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Barbara Riemke
(Division Sign-Off) Division of General, Restorative, and Neurological Devices
510(k) Number K060415/c
Image /page/4/Picture/13 description: The image shows the number 000039 followed by the number 3. The numbers are written in a slightly distressed font, giving them a worn or vintage appearance. The number 3 is written in a different font and is slightly larger than the other numbers.
